BPC-157 is studied in preclinical literature for its multi-pathway signalling profile: VEGFR2AkteNOS activation, focal adhesion kinase signalling, growth-hormone-receptor upregulation, and nitric oxide system modulation
Janaky R, Varga V, Saransaari P, Oja SS (1993)
The endogenous ligand for these GHS receptors was discovered in the stomach and hypothalamus by Kojima et al (1999), thereby establishing a new brain-gut peptide family
[21] Though the exact mechanism of action of Semax is unclear, there is evidence that it may act through melanocortin receptors
Measured response: GHK-Cu works on skin density, collagen, and hair quality
Its about metabolism, hormones, nutrition, activity levels, and consistency